Aglenova Pharmaceutical Private Limited
About Aglenova Pharmaceutical Private Limited
Data last updated:
Aglenova Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 18 December 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2024PTC440011.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dimple Lalit Tharani and Rekha Tharani.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 33 & 33A Hall 3 Pvt No 6, First Floor Shivaji Marg, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹98,877. For the same year it recorded a net profit of ₹2,648 (net margin 2.7%) and EBITDA of ₹3,538 (EBITDA margin 3.6%).
Company details
Contact details
Aglenova Pharmaceutical Private Limited's registered office is in New Delhi, Delhi.
- Registered Address33 & 33A Hall 3 Pvt No 6, First Floor Shivaji Marg, New Delhi, Delhi, India – 110015
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aglenova Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Aglenova Pharmaceutical Private Limited, buy the company report.
Financials of Aglenova Pharmaceutical Private Limited
FY 2025 filings availableAglenova Pharmaceutical Private Limited reported revenue of ₹98,877 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹3,538 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹2,648 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 3.6% |
| Net Profit Margin | 2.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Aglenova Pharmaceutical Private Limited, buy the company report.
Board of directors of Aglenova Pharmaceutical Private Limited
Aglenova Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dimple Lalit Tharani | Director | 18 Dec 2024 | 1 Years 10 Months | Current |
| Rekha Tharani | Director | 18 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Aglenova Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dav Lifecare Private Limited | ₹1.07 Lakh (FY 2025) | 43.0% | Satara, Maharashtra, India | |||
| Cutyco India Private Limited | ₹1.06 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Aviterium Immunology Private Limited | ₹1.02 Lakh (FY 2025) | -58.0% | Nagpur, Maharashtra, India | |||
| Goodheart Pharmachem Private Limited | ₹1 Lakh (FY 2025) | Jalgaon, Maharashtra, India | ||||
| Maxazan Healthcare Private Limited | ₹99,221 (FY 2025) | 133.0% | Lucknow, Uttar Pradesh, India | |||
| Aglenova Pharmaceutical Private Limitedthis company | ₹98,877 (FY 2025) | ₹2,648 | 2.7% | New Delhi, Delhi, India | ||
| Skyvin Healthcare Private Limited | ₹98,836 (FY 2025) | -86.0% | Mumbai, Maharashtra, India | |||
| Getson Pharmaceuticals Private Limited | ₹98,510 (FY 2025) | 44.0% | Delhi, India | |||
| Roykar Pharmaceuticals Private Limited | ₹97,800 (FY 2025) | -71.0% | Pune, Maharashtra, India | |||
| Serine Pharma Private Limited | ₹95,953 (FY 2025) | Mysore, Karnataka, India | ||||
| Hira Filters Private Limited | ₹95,620 (FY 2025) | -45.0% | Nalagarh, Himachal Pradesh, India |
To see the full peer comparison of Aglenova Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aglenova Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aglenova Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aglenova Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aglenova Pharmaceutical Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Dimple Lalit Tharani was appointed as Director on 18 Dec 2024.
Frequently asked questions
Aglenova Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 18 December 2024 (2+ years old) and is registered under CIN U46497DL2024PTC440011.
Aglenova Pharmaceutical has 2 current directors:
- Dimple Lalit Tharani - Director
- Rekha Tharani - Director
The latest financial statements of Aglenova Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Aglenova Pharmaceutical is U46497DL2024PTC440011. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aglenova Pharmaceutical was incorporated on 18 December 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aglenova Pharmaceutical by revenue are Dav Lifecare Private Limited, Cutyco India Private Limited, Aviterium Immunology Private Limited, Goodheart Pharmachem Private Limited, Maxazan Healthcare Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Dimple Lalit Tharani was appointed as Director on 18 Dec 2024. Rekha Tharani was appointed as Director on 18 Dec 2024.
The registered office of Aglenova Pharmaceutical is at 33 & 33A Hall 3 Pvt No 6, First Floor Shivaji Marg, New Delhi, Delhi, India – 110015.
Aglenova Pharmaceutical can be reached at its registered office: 33 & 33A Hall 3 Pvt No 6, First Floor Shivaji Marg, New Delhi, Delhi, India – 110015.
Aglenova Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
